Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 17;26(10):4812.
doi: 10.3390/ijms26104812.

Endophenotype-Informed Association Analyses for Liver Fat Accumulation and Metabolic Dysfunction in the Fels Longitudinal Study

Affiliations

Endophenotype-Informed Association Analyses for Liver Fat Accumulation and Metabolic Dysfunction in the Fels Longitudinal Study

Ariana L Garza et al. Int J Mol Sci. .

Abstract

The identification of causal genomic regions for liver fat accumulation in the context of metabolic dysfunction remains a challenging goal. This study aimed to identify potential endophenotypes for liver fat content and employ them in bivariate linkage searches for pleiotropic genetic regions where targeted association analysis is more likely to reveal significant variants. Multiple metabolic risk and adiposity distribution traits were assessed using the endophenotype ranking value. The top-ranked endophenotypes were then used in a bivariate linkage analysis, paired with liver fat content. Quantitative trait loci (QTLs) identified as significant or suggestive were targeted for measured genotype association analyses. The highest-ranked endophenotypes for liver fat accumulation were insulin resistance (IR), visceral adipose tissue (VAT), and high-density lipoprotein cholesterol (HDL-C). The univariate linkage analysis for liver fat content identified one significant QTL at chromosome 17p13.2 (Logarithm of odds score (LOD) = 2.90, p = 1.29 × 10-4). The bivariate linkage analysis pairing liver fat with IR and VAT improved the localization of two suggestive QTLs at 13q21.31 (LOD = 2.11, p = 9.03 × 10-4), and 6q21 (LOD = 2.35, p = 5.07 × 10-4), respectively. Targeted association analyses within the -1-LOD score regions of these QTLs revealed 17 marginally significant single nucleotide polymorphisms (SNPs) associated with liver fat content or its combination with the selected endophenotypes. The endophenotype-informed linkage analysis successfully identified regions suitable for the targeted association analysis of liver fat content, either alone or in combination with IR or VAT, leading to the discovery of marginally significant variants with potential for future functional studies.

Keywords: MASLD; endophenotype; family studies; genotype association; linkage.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest concerning this article.

References

    1. Ciardullo S., Carbone M., Invernizzi P., Perseghin G. Exploring the landscape of steatotic liver disease in the general US population. Liver Int. 2023;43:2425–2433. doi: 10.1111/liv.15695. - DOI - PubMed
    1. Chan K.E., Koh T.J.L., Tang A.S.P., Quek J., Yong J.N., Tay P., Tan D.J.H., Lim W.H., Lin S.Y., Huang D., et al. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals. J. Clin. Endocrinol. Metab. 2022;107:2691–2700. doi: 10.1210/clinem/dgac321. - DOI - PubMed
    1. Tokushige K., Yatsuji S., Hashimoto E., Kabutake A., Tobari M., Taniai M., Shiratori K. Familial aggregation in patients with non-alcoholic steatohepatitis. Intern. Med. 2008;47:405–410. doi: 10.2169/internalmedicine.47.0476. - DOI - PubMed
    1. Speliotes E.K., Yerges-Armstrong L.M., Wu J., Hernaez R., Kim L.J., Palmer C.D., Gudnason V., Eiriksdottir G., Garcia M.E., Launer L.J., et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 2011;7:e1001324. doi: 10.1371/journal.pgen.1001324. - DOI - PMC - PubMed
    1. Chandrasekharan K., Alazawi W. Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy? Front. Pharmacol. 2020;10:1413. doi: 10.3389/fphar.2019.01413. - DOI - PMC - PubMed

LinkOut - more resources